Skip to main content

Characterization of Taurine as Inhibitor of Sodium Glucose Transporter

  • Conference paper
Taurine 6

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 583))

1. Abstract

The most characterized roles of taurine include osmoregulator and membrane-stabilizing activities. However, much remains to be understood about its role in human physiology concerning its anti-hyperglycemic effect. Studies indicate that taurine-supplemented diet helps alleviate hyperglycemia or insulin resistance. This hypoglycemic effect has been postulated as taurine helping to increase the excretion of cholesterol. Alternatively, this study investigated the effect of taurine on glucose transporter using heterologous expression of sodium-glucose transporter-1 (SGLT-1). SGLT-1 was expressed in Xenopus oocytes and the effect of taurine on the expressed SGLT-1 was analyzed utilizing 2-deoxy-D-glucose (2-DOG) uptake and voltage clamp studies. In the oocytes expressing SGLT-1, taurine was shown to inhibit SGLT-1 activity compared to the non-treated controls in a dose-dependent manner. In the presence of taurine, the glucose uptake was greatly inhibited and the glucose-generated current was significantly inhibited. Synthetic taurine analogs were also shown to be effective in inhibiting SGLT-1 activity in a manner comparable to taurine. These effects might offer a promising opportunity in designing functional foods with anti-hyperglycemic potential by supplementing taurine and its analogs to the diet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

7. References

  • Ader, P., Blöck, M., Pietzsch, S., and Wolffram, S., 2001, Interaction of quercetin glucosides with the Na+-dependent glucose carrier (SGLT1) in rat small intestine, Cancer Lett. 162:175.

    Article  PubMed  CAS  Google Scholar 

  • Arany, E., Strutt, B., Romanus, P., Remacle, C., Reusens, B., and Hill, D. J., 2004, Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice, Diabetologia 47:1831.

    Article  PubMed  CAS  Google Scholar 

  • Di Leo, M. A., Santini, S. A., Silveri, N. G., Giardina, B., Franconi, F., and Ghirlanda, G., 2004, Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats, Amino Acids 27:187.

    Article  PubMed  CAS  Google Scholar 

  • Doege, H., Bocianski, A., and Joost, H. G., 2000, Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leukocytes, Biochem. J. 350:771.

    Article  PubMed  CAS  Google Scholar 

  • Hansen, S. H., 2001, The role of taurine in diabetes and the development of diabetic complications, Diabetes Metab. Res. Rev. 17:330.

    Article  PubMed  CAS  Google Scholar 

  • Lee, D. H., 1998, Characterization of 27K zein as a transmembrane protein. J. Biochem. Mol. Biol. 31:196.

    CAS  Google Scholar 

  • Lee, D. H., Selester, B, and Pedersen, K., 1995, Free movement of 27K zein in the endoplasmic reticulum, Protein Eng. 9:91.

    Article  CAS  Google Scholar 

  • Mandal, A. Verri, T, Mandal, P. K., Storelli, C., and Ahearn, G.A., 2003, Expression of Na+/D-glucose cotransport in Xenopus laevis oocytes by injection of poly(A)(+)RNA isolated from lobster (Homarus americanus) hepatopancreas, Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 135:467.

    Article  PubMed  CAS  Google Scholar 

  • Oulianova, N., Falk, S., and Berteloot, A., 2001, Two-step mechanism of phroridzin binding to the SGLT1 protein in the kidney, J. Membr. Biol. 179:223.

    Article  PubMed  CAS  Google Scholar 

  • Satsu, H., Terasawa, E., Hosokawa, Y., and Shimizu, M., 2003, Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells, Biochem J. 375:441.

    Article  PubMed  CAS  Google Scholar 

  • Scheepers, A., Joost, H. G., and Schurmann, A., 2004, The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function, J. Parent. Enteral Nutr. 28:364.

    CAS  Google Scholar 

  • Takashi, M, Satsu, H, and Shimizu, M., 2004, Physiological significance of the taurine transporter and taurine biosynthetic enzymes in 3T3-L1 adipocytes, Biofactors 21:419.

    Google Scholar 

  • Wood, I. S. and Trayhurn, P., 2003, Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins, Br. J. Nutr. 89:3.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this paper

Cite this paper

Kim, H., Lee, A.J., You, S., Park, T., Lee, D.H. (2006). Characterization of Taurine as Inhibitor of Sodium Glucose Transporter. In: Oja, S.S., Saransaari, P. (eds) Taurine 6. Advances in Experimental Medicine and Biology, vol 583. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-33504-9_14

Download citation

Publish with us

Policies and ethics